Log in to save to my catalogue

Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell...

Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1524419494

Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

About this item

Full title

Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2014-01, Vol.20 (1), p.87-92

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

Subjects

Subjects and topics

More information

Scope and Contents

Contents

A screen for compounds that may inhibit the growth of hematological malignancies reveals the specific dependence of some mantle cell lymphoma (MCL) cell lines on canonical or alternative NF-κB signaling. As also seen in patients, genetic alterations affecting alternative NF-κB signaling confer insensibility to ibrutinib, a compound that was recentl...

Alternative Titles

Full title

Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1524419494

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1524419494

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.3435

How to access this item